Connecticut College is committed to the health and safety of its community members and strives to prevent the harm that may result from the misuse and abuse of opioid substances. Accordingly, the ...

Purpose. Published reports on placebo-controlled clinical trials and other studies investigating the use of pure opioid antagonists for the prevention and treatment of opioid-induced pruritus (OIP ...

Mixed results were seen in the studies evaluating the use of opioid antagonists for the prevention of OIP. While oral naltrexone provided some benefit in some studies and its use would be more ...

Young Australians are taking the opioid reversal drug naloxone with them on nights out. We've unpacked what it is and how it ...

Naloxone has no pharmacological properties of its own but it is a narcotic antagonist that powerfully counteracts the euphoria, respiratory depression, nausea, convulsions, and other effects produced ...

Avoid concomitant mixed agonist/antagonist opioids (eg, butorphanol, nalbuphine, pentazocine) or partial agonist (eg, buprenorphine); may reduce effects and/or precipitate withdrawal symptoms.

Avoid concomitant mixed agonist/antagonist opioids (eg, butorphanol, nalbuphine, pentazocine) or partial agonist (eg, buprenorphine); may reduce effects and/or precipitate withdrawal symptoms.

BMB-201's efficacy suggests that it may provide better pain relief than traditional opioid treatments, without the associated risks of dependency ... Our pipeline includes novel compounds targeting ...

Opioid antagonists such as naloxone are administered to people suspected of overdosing. Naloxone — known mostly by the commercial nasal spray container that administrates it called Narcan ...